Response Genetics (RGDXQ)
OTHER OTC:RGDXQ
US Market
Holding RGDXQ?
Track your performance easily

Response Genetics (RGDXQ) Financial Statements

9 Followers

Response Genetics Financial Overview

Response Genetics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Response Genetics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 15Dec 14Sep 14Jun 14Mar 14
Income Statement-
Total Revenue$ 3.79M$ -2.44M$ 4.46M$ 4.28M$ 3.89M
Gross Profit$ 1.48M$ -3.33M$ 1.92M$ 1.70M$ 1.46M
EBIT$ -3.64M$ -8.54M$ -3.38M$ -3.12M$ -3.48M
EBITDA$ -3.45M$ -8.33M$ -3.18M$ -2.90M$ -3.27M
Net Income Common Stockholders$ -4.02M$ -6.36M$ -3.64M$ -3.14M$ -3.50M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.73M$ 25.55M$ 5.96M$ 2.14M$ 4.96M
Total Assets$ 10.78M$ 47.10M$ 16.26M$ 12.22M$ 14.36M
Total Debt$ 10.94M$ 6.92M$ 9.66M$ 1.70M$ 1.25M
Net Debt$ 9.21M$ -18.64M$ 3.70M$ -440.55K$ -3.71M
Total Liabilities$ 15.72M$ 12.55M$ 14.25M$ 7.21M$ 11.92M
Stockholders Equity$ -4.94M$ 34.55M$ 2.01M$ 5.01M$ 2.43M
Cash Flow-
Free Cash Flow$ -1.88M$ -3.17M$ -4.25M$ -3.27M$ -3.14M
Operating Cash Flow$ -1.88M$ -1.76M$ -4.30M$ -3.18M$ -3.10M
Investing Cash Flow$ -2.41K$ -11.29M$ 49.27K$ -90.46K$ -44.56K
Financing Cash Flow$ 1.42M$ -8.69M$ 8.07M$ 455.91K$ -30.30K
Currency in USD

Response Genetics Earnings and Revenue History

Response Genetics Debt to Assets

Response Genetics Cash Flow

Response Genetics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis